NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Wednesday reported a loss of $2.1 million in its fiscal third quarter.
On a per-share basis, the New York-based company said it had a loss of 5 cents. Losses, adjusted for non-recurring costs, came to 4 cents per share.
The life sciences and biotechnology company posted revenue of $26.4 million in the period.
Enzo Biochem shares have increased 35 percent since the beginning of the year. The stock has more than doubled in the last 12 months.
Sentiment: Strong Buy